Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnglo-Eastern Plantations Regulatory News (AEP)

Share Price Information for Anglo-Eastern Plantations (AEP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 690.00
Bid: 688.00
Ask: 698.00
Change: 0.00 (0.00%)
Spread: 10.00 (1.453%)
Open: 692.00
High: 698.00
Low: 690.00
Prev. Close: 690.00
AEP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

21 Aug 2009 09:30

RNS Number : 8119X
Anglo-Eastern Plantations PLC
21 August 2009
 



21 August 2009

Anglo-Eastern Plantations PLC ("AEP" or "Company")

Interim Results for the six months ended 30 June 2009

Anglo-Eastern Plantations PLC, which owns approximately 132,000 hectares of plantation land, primarily in Indonesia, is pleased to announce the interims results for the six months to 30 June 2009.

Financial Highlights

Revenue of $57.4m (H1 2008: $100.2m)

Operating profit for the period was $23.5m ( H1 2008: $43.8m)

Profit before tax decreased to $24m from $44.4m in the first half of 2008

Basic earnings per share were 35.6cts (H1 2008: 61.6cts)

Net cash at 30 June 2009 was $24.6m compared with $33.8m at the year end and $35.7m at 30 June 2008

Commercial Highlights

The market average price for crude palm oil for the period was $650 a fall of 80% on the average of $1,169 for the first half of 2008

Total own crop production was 283,366 tonnes an increase of 7% on June 2008

Planting of 7,400 ha of new areas to begin by the year end

Construction of 40/60mt oil mill at Sumindo estate in Bengkulu is under progress and is expected to be completed in Q1 2010.

For further information, contact:

Anglo-Eastern Plantations plc

Donald Low 

Tel 020 7216 4600 / +603 2715 0118

Charles Stanley Securities

Russell Cook / Jen Boorer

Tel 020 7149 6000

Chairman's interim statement

Operational and financial performance

For the first half-year ended 30 June 2009, revenue was $57.4 million compared to $100.2 million for the same period in 2008. This generated an operating profit of $23.5 million (H1 2008: $43.8 million), a decrease of 46%. Profit before tax was $24.0 million, compared to $44.4 million in the same period in 2008.

The decrease in revenue and operating profit is due to market corrections in the Rotterdam CIF crude palm oil (CPO) price, in line with other commodities' prices, from the exceptional levels reached during the first half of 2008. In the year 2008, CPO prices rose sharply and peaked in March at $1,420 and ended around $500 in December, registering an average price of $950. In the first half of 2009, the average CPO price has been around $650.

With a net cash position, the group's balance sheet remains strong while cash flow remains positive. As at 30 June 2009 the Group's total cash balance was $57.9 million with total borrowings of $33.3 million, giving a net cash position of $24.6 million, down from $33.8 million recorded at 31 December 2008, as a result of higher capital expenditure and repayment of some tranches of long term loan that were due. There were no new borrowings.

Earnings per share were 35.6cts (2008: 61.6cts). 

No new acquisition during the period

The Group made no further acquisitions in the first 6 months of the financial year, following 3 major acquisitions in the year of 2008 totalling 45,100 ha of plantation lands in the region of South Sumatra.

Operating costs 

Even though the Indonesian government removed some fuel subsidies and fertiliser prices doubled in 2008, the Group was able to contain rising input costs in H1 2009 through careful planning on the usage of fertilisers and planting schedules.

Production and Sales

2009

2008

2008

6 months

6 months

Year

to 30 June

to 30 June

to 31 Dec

(unaudited)

(unaudited)

(audited)

mt

mt

mt

Oil palm production

FFB

- all estates

283,366

265,508

566,540

- bought-in or processed for third parties

224,463

206,979

443,274

Saleable CPO

102,852

95,549

203,728

Saleable palm kernels

25,152

22,368

47,971

Oil palm sales

CPO

97,609

93,008

206,059

Palm kernels

25,762

22,304

46,943

FFB sold outside

14,303

16,402

40,185

Rubber production

352

416

950

Production was higher than last yearup marginally in the older North Sumatra estates, up 24% in Riau and up 11% in Bengkulu. Underlying yield improvements are consistent with the average age of the palms.

The higher CPO production volume was due to better utilisation rate of the Group's four mills, with higher bought-in fresh fruit bunches ('FFB') volume and relatively higher internal crop. Total own crop processed in H1 2009 wa283,366 tonnes, 7% higher than H1 2008.

Bought-in crops for the period were 224,463 tonnes, 8.5% higher than last year. Outside fruit continues to be available at prices which allow positive contributions to profit.

  Commodity prices

The CPO price, which ended in December 2008 at around $500/mt, has continued its recovery trend since, reaching a high of about $800/mt, and averaging $650/mt for the six months ended 30 June 2009. The rise in CPO price since December 2008, as witnessed in other competing vegetable oils, is attributable to the recovery in fundamental demand as well as to the tighter inventory level of global oil seeds production. As reported in our 2008 Annual Report, the industry generally feels that the long term sustainable price is $600 to $700/mt as the underlying demand from the traditional edible oil markets such as India and China remains strong.

Rubber prices averaged around $1,330/mt (2008: $2,750/mt).

Development

The Group's planted areas at 30 June 2009 were:-

Total

Mature

Immature

ha

ha

ha

North Sumatra

 20,924

11,311

9,613

Bengkulu

16,499

13,248

3,251

Riau 

4,960

4,943

17

Indonesia

42,383

29,502

12,881

Malaysia

3,696

3,425

271

Total at 30 June 2009

46,079

32,927

13,152

Total at 31 December 2008

40,264

32,977

7,287

Total at 30 June 2008

39,584

33,543

6,041

The Group's development is on schedule, with 2,045 ha already planted with oil palm seedlings during the first half-year of 2009.

The Group targets to commence planting in another 7,400 ha of new areas in Bengkulu, North Sumatra and Kalimantan by the year end. In addition, land preparation, which involves compensation negotiation with local villagers and land clearing for 1,500 ha of land in the newly acquired region of South Sumatra and Bangka, is targeted for completion by the end of the year. The Group has sufficient seedlings available to plant up 10,000 hectares. 

Out of the Group's total landholding of 132,000 ha, the planted area now stands at 46,000 ha (2008: 40,000) with 58,000 ha available for planting.

The construction of a 40/60mt oil mill located at Sumindo estate in Bengkulu is under progress and the mill is expected to be commissioned by the first quarter of 2010.

Dividend

As in previous years no interim dividend has been declared. A final dividend of 5.0 cents per share in respect of the year to 31 December 2008 was paid on 7 August 2009.

Risks and Uncertainties

The principal risks facing the business are as set out on page 10 of the 2008 annual report, and there have been no changes this year. 

Outlook

Although production has grown as planned and commodity prices have remained generally stable throughout the period, the global recessionary market sentiment does create some uncertainty going forward.

Despite the unfavourable economic outlook demand for the Group's products remains strong. The board remains cautiously confident of reporting a satisfactory profit level and cash flow for the second half of 2009.

Chan Teik Huat 21 August 2009

Chairman

Responsibility Statements

We confirm that to the best of our knowledge:

a) The interim financial statements have been prepared in accordance with IAS34; Interim Reporting as adopted by the European Union:

b) The Chairman's statement includes a fair review of the information required by DTR 4.2.7R (indication of important events during the first six months and description of principal risks and uncertainties for the remaining six months of the year); and

c) The interim financial statements include a fair review of the information required by DTR 4.2.8R (disclosure of related party transactions and changes therein).

By order of the Board

Donald Han Low 21 August 2009

Consolidated income statement

2009

6 months to 30 June

(unaudited)

2008

6 months to 30 June

(unaudited)

2008

year to 31 December

(audited)

Continuing operations

Notes

Result before BA adjustment $000

BA adjustment $000

Total $000

Result before BA adjustment $000

BA adjustment $000

Total $000

Result before BA adjustment $000

BA adjustment $000

Total $000

Revenue

57,361

-

57,361

100,179

-

100,179

174,684

-

174,684

Cost of sales

(32,714)

-

(32,714)

(54,777)

-

(54,777)

(96,812)

-

(96,812)

Gross profit

24,647

-

24,647

45,402

-

45,402

77,872

-

77,872

Biological asset revaluation movement (BA adjustment)

2

-

417

417

-

489

489

-

1,347

1,347

Other income

278

-

278

151

-

151

-

-

-

Administration expenses

(1,871) 

-

(1,871)

(2,234)

-

(2,234)

(3,808)

-

(3,808)

Operating profit

23,054

417

23,471

43,319

489

43,808

74,064

1,347

75,411

Exchange profit/(losses)

3

252

-

252

618

-

618

1,503

-

1,503

Finance income

1,532

-

1,532

1,254

-

1,254

3,645

-

3,645

Finance costs

4

(1,220)

-

(1,220)

(1,237)

-

(1,237)

(2,686)

-

(2,686)

Profit before tax

5

23,618

417

24,035

43,954

489

44,443

76,526

1,347

77,873

Tax

6

( 7,029)

(117)

(7,146) 

(14,567)

(140)

(14,707)

(25,487)

(404)

(25,891)

Profit for the period

16,589

300

16,889

29,387

349

29,736

51,039

943

51,982

Attributable to:

- equity holders of the parent

13,857

198

14,055

24,019

275

24,294

41,182

819

42,001

- minority interests

2,732

102

2,834

5,368

74

5,442

9,857

124

9,981

16,589

300

16,889

29,387

349

29,736

51,039

943

51,982

Earnings per share

- basic

35.6cts 

61.6cts

105.1cts

- diluted

35.6cts

61.5cts

104.8cts

Consolidated statement of comprehensive income and expenses

2009

2008

2008

6 months

6 months

Year

to 30 June

to 30 June

to 31 Dec

(unaudited)

(unaudited)

(audited)

Notes

$000

$000

$000

Profit for the period

10

16,889

29,736

51,982

Other comprehensive income:

Unrealised (deficit)/surplus on 

revaluation of the estates

10

3,672

(2,110)

5,302

Profit/(loss) on exchange translation of foreign operations

10

5,827

4,575

(29,944)

Deferred tax on revaluation

10

108

374

(1,128)

Other comprehensive income/(expense) for the period

9,607

2,839

(25,770)

Total comprehensive income for the period

26,496

32,575

26,212

Attributable to:

- equity holders of the parent

10

21,550

26,663

19,872

- minority interest

10

4,946

5,912

6,340

26,496

32,575

26,212

  Consolidated balance sheet

2009

2008

2008

as at 30 June

as at 30 June

as at 31 Dec

(unaudited)

(unaudited)

(audited)

Notes

$000

$000

$000

Non-current assets

Biological assets

2

38,373

41,204

38,843

Property, plant and equipment

181,393

159,219

160,012

Receivables

1,677

1,677

1,677

221,443

202,100

200,532

Current assets

Inventories

6,343

7,775

4,196

Tax receivables 

1,864

912

761

Trade and other receivables

2,892

5,178

4,143

Cash and cash equivalents

57,878

78,009

69,442

68,977

91,874

78,542

Current liabilities

Bank loans and other financial liabilities

(9,032)

(9,827)

(8,639)

Trade and other payables

(6,317)

(10,973)

(10,749)

Tax liabilities

(2,053)

(8,656)

(10,428)

(17,402)

(29,456)

(29,816)

Net current assets

51,575

62,418

48,726

Non-current liabilities

Bank loans and other financial liabilities

(24,223)

(32,504)

(27,025)

Deferred tax liabilities

(28,290)

(23,035)

(28,450)

Retirement benefit, net liabilities

(1,679)

(1,483)

(1,494)

Net assets

218,826

207,496

192,289

Equity

Share capital

15,504

15,504

15,504

Treasury shares

(1,744)

(1,785)

(1,785)

Share premium reserve

10

23,935

23,935

23,935

Share capital redemption reserve

10

1,087

1,087

1,087

Revaluation and exchange reserves

10

(14,588)

2,415

(22,083)

Retained earnings

10

158,128

131,478

144,073

Equity attributable to equity holders of 

the parent

182,322

172,634

160,731

Minority interests

10

36,504

34,862

31,558

Total equity

218,826

207,496

192,289

Consolidated cash flow statement

Cash flows from operating activities

2009

2008

2008

6 months 

6 months 

Year

to 30 June

to 30 June

to 31 Dec

(unaudited)

(unaudited)

(audited)

$000

$000

$000

Profit before tax

24,035

44,443

77,873

Adjustments for:

Biological asset adjustment

(417)

(489)

(1,347)

Net profit on disposal of fixed and current asset investments

-

(5)

-

Loss/(profit) on disposal of tangible fixed assets

12

-

(53)

Depreciation

2,214

2,423

4,902

Share-based remuneration expense

-

40

-

Retirement benefit provisions

185

(51)

40

Net finance income

312

(17)

(959)

Operating cash flow before changes in working capital

26,341

46,344

80,456

(Increase)/decrease in inventories

(2,147)

(2,865)

712

(Increase)/decrease in trade and other receivables

148

(3,716)

(2,730)

(Decrease)/increase in trade and other payables

(4,432)

(1,424)

(3,935)

Cash flow from operations

19,910

38,339

74,503

Interest paid

(1,220)

(1,237)

(2,728)

Overseas tax paid

(10,428)

(12,789)

(17,898)

Net cash flow from operations

8,262

24,313

53,877

Investing activities

Acquisition of subsidiaries

-

(3,982)

(11,363)

Property, plant and equipment

- purchase

(15,110)

(9,317)

(19,738)

- sale

28

26

489

Interest received

1,532

1,254

3,645

Net cash used in investing activities

(13,550)

(12,019)

(26,967)

Financing activities

Dividends paid by parent company

-

-

(5,112)

Share options exercised

32

-

-

Repayment of existing long term loans

(4,320)

(684)

(4,237)

Finance lease (repayment)/drawdown

(9)

(2)

(110)

Dividends paid to minority shareholders

-

(575)

(2,378)

Repayment of loan by minority shareholder

-

-

48

Net cash used in financing activities

(4,297)

(1,261)

(11,789)

(Decrease)/Increase in cash and cash equivalents

(9,585)

11,033

15,121

Cash and cash equivalents less overdrafts

At beginning of period

69,442

63,357

63,357

Foreign exchange

(1,979)

618

(9,036)

At end of period

57,878

75,008

69,442

Comprising:

Cash at end of period

57,878

78,009

69,442

Overdraft at end of period

-

(3,001)

-

57,878

75,008

69,442

Notes to the interim statements

1. Basis of preparation of interim financial statements

This interim report does not constitute the company's statutory accounts. The information presented in relation to 31 December 2008 is extracted from the statutory financial statements for the year then ended and which have been delivered to the Registrar of Companies. The auditors report on the statutory financial statements for the year ended 31 December 2008 was unqualified, did not include references to any matters to which the auditors drew attention by way of emphasis without qualifying their report(s) and did not contain statements under S237(2) or (3) of the Companies Act 1985

The interim statements for the six months ended 30 June 2009 and 30 June 2008 have neither been audited nor reviewed pursuant to guidance issued by the Auditing Practices Board. Those for the six months ended 30 June 2009 were approved by the board on 21 August 2009. The same accounting policies have been followed as in the last set of statutory accounts except for the adoption of IAS 1 revised and IFRS 8 which will be applied in the full annual financial statements. These new policies affect presentation only. These interim financial statements have been prepared in accordance with IAS 34 'Interim Financial Reporting' as adopted by the EU, the requirements of the Disclosure and Transparency Rules issued by the Financial Services Authority and the accounting policies, and methods of computation as applied in the group's 2008 Annual Report and Accounts. The comparative figures for the year ended 31 December 2008 are an extract from the audited financial statements for the year. All comparative figures have been restated for the change in presentation as a result of the adoption of IAS 1 revised and IFRS 8.

2. Biological assets

Group fixed assets are valued in total on the same "value in use" basis as disclosed in the group's accounting policies within the annual financial statements. Within this total, the value of biological assets has been estimated separately and, as required by IAS41, the movement in valuation surplus of biological assets has been charged or credited (BA adjustment) to the income statement for the relevant period.

  

3. Foreign exchange

2009

2008

2008

6 months

6 months

Year

to 30 June

to 30 June

to 31 Dec

(unaudited)

(unaudited)

(audited)

Average exchange rates

Rp : $

11,000

9,254

9,735

$ : £

1.51

1.97

1.84

RM : $

3.59

3.22

3.34

Closing exchange rates

Rp : $

10,208

9,220

10,950

$ : £

1.65

1.99

1.41

RM : $

3.52

3.27

3.48

4. Finance costs

2009

2008

2008

6 months 

6 months 

Year

to 30 June

to 30 June

to 31 Dec

(unaudited)

(unaudited)

(audited)

$000

$000

$000

Payable

1,220

1,237

2,728

Capitalised

-

-

(42)

1,220

1,237

2,686

5. Segment information

Revenues

2009

2008

2008

6 months 

6 months 

Year

to 30 June

to 30 June

to 31 Dec

(unaudited)

(unaudited)

(audited)

$000

$000

$000

North Sumatra

30,737

45,896

83,022

Bengkulu

19,491

35,129

53,378

South Sumatra

-

-

-

Riau

5,364

15,566

31,280

Bangka

-

-

-

Kalimantan

-

-

-

Total Indonesia

55,592

96,591

167,680

Malaysia

1,769

3,588

7,004

UK

-

-

-

Total

57,361

100,179

174,684

  

Profit/(loss) before tax

2009

2008

2008

6 months 

6 months 

Year

to 30 June

to 30 June

to 31 Dec

(unaudited)

(unaudited)

(audited)

$000

$000

$000

North Sumatra

12,458

23,386

46,788

Bengkulu

8,265

14,629

16,355

South Sumatra

-

-

-

Riau

5,222

5,504

13,266

Bangka

-

-

-

Kalimantan

-

-

-

Total Indonesia

25,945

43,519

76,409

Malaysia

320

1,739

2,553

UK

(2,230)

(815)

(1,089)

Total

24,035

44,443

77,873

Total assets

2009

2008

2008

30 June

30 June

31 Dec

(unaudited)

(unaudited)

(audited)

$000

$000

$000

North Sumatra

128,991

126,717

113,332

Bengkulu

39,072

40,461

43,379

South Sumatra

14,155

-

13,392

Riau

25,829

26,166

24,545

Bangka

1,443

2,071

1,342

Kalimantan

9,901

8,219

7,202

Total Indonesia

219,391

203,634

203,192

Malaysia

24,986

25,925

26,434

UK

4,792

9,628

1,541

Total

249,169

239,187

231,167

6. Tax

2009

2008

2008

6 months 

6 months 

Year

to 30 June

to 30 June

to 31 Dec

(unaudited)

(unaudited)

(audited)

$000

$000

$000

Foreign corporation tax

6,773

12,645

20,552

Foreign withholding tax

-

1,664

4,550

Deferred tax adjustment

373

398

789

7,146

14,707

25,891

7. Dividend

The final and only dividend in respect of 2008, amounting to 5.0cts per share, or $1,973,514, was paid on 7 August 2009 (2007: 14.0cts per share, or $5,531,000, paid on 9 September 2008). In common with previous years no interim dividend has been declared.

8. Earnings per share

2009

2008

2008

6 months

6 months

Year

to 30 June

to 30 June

to 31 Dec

(unaudited)

(unaudited)

(audited)

$000

$000

$000

Earnings before BA adjustment

13,857

24,019

41,182

Net BA adjustment

198

275

819

Earnings after BA adjustment

14,055

24,294

42,001

Number

Number

Number

000

000

000

Weighted average number of shares in issue in period

- used in basic EPS

39,470

39,458

39,976

- dilutive effect of outstanding share options

34

63

101

- used in diluted EPS

39,504

39,521

40,077

Shares in issue at period end excluding 506,000 shares held in treasury

39,470

39,458

39,976

Basic earnings per share before BA adjustment

35.1cts

60.9cts

103.0cts

Basic earnings per share after BA adjustment

35.6cts

61.6cts

105.1cts

9 Post balance sheet events

No major events or transactions occurred between the balance sheet and the date of this report.

10. Reserves and minority interests

Attributable to equity holders of the parent

Share

capital

Treasury

shares

Share

premium

Share

capital

redemption

reserve

Revaluation

Reserve

Foreign

exchange

reserve

Retained

earnings

Total

Minority

interests

Total

equity

$000

$000

$000

$000

$000

$000

$000

$000

$000

$000

Balance at 31 December 2007

15,504

(1,785)

23,935

1,087

76,445

(76,399)

107,184

145,971

32,367

178,338

Direct changes in equity for 2007

Unrealised surplus on revaluation of estates

-

-

-

-

3,670

-

-

3,670

1,632

5,302

Deferred tax on revaluation

-

-

-

-

(533)

(375)

-

(908)

(220)

(1,128)

(Loss) on exchange translation

-

-

-

-

-

(24,891)

-

(24,891)

(5,053)

(29,944)

Net income and expense recognised directly in equity

-

-

-

-

3,137

(25,266)

-

(22,129)

(3,641)

(25,770)

Profit for year

-

-

-

-

-

-

42,001

42,001

9,981

51,982

Total comprehensive income and expense for the year

-

-

-

-

3,137

(25,266)

42,001

19,872

6,340

26,212

Dividends paid

-

-

-

-

-

-

(5,112)

(5,112)

(7,747)

(12,859)

Interest in subsidiaries acquired

-

-

-

-

-

-

-

-

598

598

  

Balance at 31 December 2008

15,504

(1,785)

23,935

1,087

79,582

(101,665)

144,073

160,731

31,558

192,289

Direct changes in equity for six months to 30 June 2009

Unrealised surplus on revaluation of estates

-

-

-

-

2,985

-

-

2,985

687

3,672

Deferred tax on revaluation

-

-

-

-

(295)

372

-

77

31

108

Profit on exchange translation

-

-

-

-

-

4,433

-

4,433

1,394

5,827

Net income and expense recognised directly in equity

-

-

-

-

2,690

4,805

-

7,495

2,112

9,607

Profit for period

-

-

-

-

-

-

14,055

14,055

2,834

16,889

Total comprehensive income and expense for the period

-

-

-

-

2,690

4,805

14,055

21,550

4,946

26,496

Share option exercised 

-

41

-

-

-

-

-

41

-

41

Balance at 30 June 2009

15,504

(1,744)

23,935

1,087

82,272

(96,860)

158,128

182,322

36,504

218,826

  

Attributable to equity holders of the parent

Share

capital

Treasury

shares

Share

premium

Share

capital

redemption

reserve

Revaluation

Reserve

Foreign

exchange

reserve

Retained

earnings

Total

Minority

interests

Total

equity

$000

$000

$000

$000

$000

$000

$000

$000

$000

$000

Balance at 31 December 2007

15,504

(1,785)

23,935

1,087

76,445

(76,399)

107,184

145,971

32,367

178,338

Direct changes in equity for six months to 30 June 2008

Unrealised surplus on revaluation of estates

-

-

-

-

(1,787)

-

-

(1,787)

(323)

(2,110)

Deferred tax on revaluation

-

-

-

-

368

-

-

368

6

374

Profit on exchange translation

-

-

-

-

-

3,788

-

3,788

787

4,575

Net income and expense recognised directly in equity

-

-

-

-

(1,419)

3,788

-

2,369

470

2,839

Profit for period

-

-

-

-

-

-

24,294

24,294

5,442

29,736

Total recognised income and expense for the period

-

-

-

-

(1,419)

3,788

24,294

26,663

5,912

32,575

Dividends paid

-

-

-

-

-

-

-

-

(3,620)

(3,620)

Interest in subsidiaries acquired

-

-

-

-

-

-

-

-

203

203

Balance at 30 June 2008

15,504

(1,785)

23,935

1,087

75,026

(72,611)

131,478

172,634

34,862

207,496

11 Report and Financial Information

Copies of the interim report for the Company for the period ended 30 June 2009 are to be made available on the Company's website.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR IIFFTTSILFIA
Date   Source Headline
9th May 20249:12 amRNSDividend Declaration
9th May 20247:00 amRNSTransaction in Own Shares
8th May 20247:00 amRNSTransaction in Own Shares
7th May 20247:00 amRNSTransaction in Own Shares
2nd May 20247:00 amRNSTransaction in Own Shares
30th Apr 20245:00 pmRNS2023 Annual Report & Accounts
30th Apr 202411:00 amRNSDirectorate Change
30th Apr 20247:05 amRNSFinal results for year ended 31 December 2023
24th Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20243:46 pmRNSFirst Commercial BioCNG Plant Completed
31st Jan 20247:00 amRNSTransaction in Own Shares
30th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
9th Jan 20247:00 amRNSTransaction in Own Shares
29th Dec 20239:05 amRNSTransaction in Own Shares
28th Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 202312:31 pmRNSUpdate Statement on 2023 Annual GM Voting Results
21st Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20237:00 amRNSTransaction in Own Shares
15th Dec 20237:00 amRNSTransaction in Own Shares
14th Dec 20237:00 amRNSTransaction in Own Shares
13th Dec 20239:09 amRNSTransaction in Own Shares
8th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
30th Nov 20239:29 amRNSConsolidation of Holdings-Indonesian Subsidiaries
29th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
16th Nov 20237:00 amRNSTransaction in Own Shares
14th Nov 20237:00 amRNSTransaction in Own Shares
13th Nov 20237:00 amRNSTransaction in Own Shares
9th Nov 20237:00 amRNSTransaction in Own Shares
7th Nov 20237:00 amRNSTransaction in Own Shares
6th Nov 20237:00 amRNSTrading Statement
2nd Nov 20237:00 amRNSTransaction in Own Shares
31st Oct 20237:00 amRNSTransaction in Own Shares
25th Oct 20237:00 amRNSTransaction in Own Shares
20th Oct 20238:59 amRNSTransaction in Own Shares
19th Oct 20237:00 amRNSTransaction in Own Shares
12th Oct 20237:00 amRNSTransaction in Own Shares
10th Oct 20237:00 amRNSTransaction in Own Shares
6th Oct 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.